Because it’s Triple Negative Breast Cancer Day.
Barbra Watson-Riley
Triple Negative Breast Cancer (TNBC) Day, organized by the TNBC Foundation, Inc., is an annual global awareness and grassroots fundraising campaign to help eradicate triple negative breast cancer.
Our Pinkwellchick Foundation, Inc. (PWCF) founder, Barbra Watson-Riley, was diagnosed with triple negative breast cancer, a very aggressive form of breast cancer that is more likely to recur and more difficult to treat because there is no targeted treatment. It is also more likely to affect younger women and women of color.
Despite undergoing a double mastectomy, chemotherapy and radiation, Barbra died in 2013 at the age of 44, just two years after her diagnosis.
In addition to the work we do to support breast cancer patients and their caregivers through Barb’s Bag® and LIFE in the CANCER Lane productions, we also support organizations like TNBC Foundation, Inc., because of its tremendous commitment to support and fund breakthrough research to discover and develop promising new treatments for TNBC Patients.
In honor of TNBC Day, please LIKE and share this fact-filled post with three people and ask that they do the same. Also give to PWCF today to further our charitable efforts to support and encourage patients and to find a cure!
TNBC Facts
[Source: TNBCFoundation.org]
Triple negative breast cancer (TNBC) is one of many forms of breast cancer.
Forms of breast cancer are generally diagnosed based on the presence or absence of three “receptors” known to fuel most breast cancer tumors: estrogen, progesterone and HER2‐neu.
A diagnosis of TNBC means that the tumor in question is estrogen‐receptor negative, progesterone‐receptor negative and Her2‐negative. In other words, triple negative breast cancer tumors do not exhibit any of the three known receptors.
Receptor‐targeting therapies have fueled tremendous recent advances in the fight against breast cancer. Unfortunately, there is no such targeted therapy for triple negative breast cancer.
TNBC tends to be more aggressive, more likely to recur, and more difficult to treat because there is no targeted treatment.
TNBC disproportionately strikes younger women, African American women, and those with BRCA1 mutations.
Approximately every half hour, another woman in the US is diagnosed with triple negative breast cancer.
PinkWellChick Foundation, Inc. 
Join the conversation!